marketcaparena
Search

    AKBA

    Akebia Therapeutics, Inc.

    Company overview

    Market capitalization
    $247.48M
    Employees
    194
    Latest publication
    2026-09-29
    About Akebia Therapeutics, Inc.

    Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. Its product portfolio includes Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, for the treatment of anemia due to chronic kidney disease (CKD) in dialysis-dependent (DD) and non-dialysis dependent (NDD) patients; and Auryxia, a ferric citrate that is used to control the serum phosphorus levels in adult patients with DD-CKD and the treatment of iron deficiency anemia in adult patients with NDD-CKD. The company is also developing AKB-9090, which is in Phase 2 clinical trial for treating cardiac surgery-related acute kidney injury and acute respiratory distress syndrome; and AKB-10108 for the treatment of retinopathy of prematurity in neonates. The company has license and collaboration agreements with Tanabe Pharma Corporation for the development and commercialization of Vafseo in Japan and other Asian countries; Vafseo License and Collaboration Agreements; CSL Vifor Agreements; Averoa License Agreement; License Agreement with Panion & BF Biotech, Inc.; Cyclerion Therapeutics License Agreement; and Q32 Asset Purchase Agreement. Akebia Therapeutics, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20232023-12-31 · USDQ4 20172017-12-31 · USDQ3 20172017-09-30 · USDQ2 20172017-06-30 · USD
    Total Revenue49,128,000USD58,766,000USD62,472,000USD57,336,000USD56,196,000USD87,316,000USD41,283,000USD28,520,000USD
    Cost Of Revenue10,424,000USD9,701,000USD9,919,000USD7,625,000USD18,665,000USD68,382,000USD58,711,000USD43,751,000USD
    Gross Profit38,704,000USD49,065,000USD52,553,000USD49,711,000USD37,531,000USD18,934,000USD-17,428,000USD-15,231,000USD
    Research Development14,059,000USD14,626,000USD11,013,000USD9,754,000USD9,865,000USD68,382,000USD58,711,000USD43,751,000USD
    Selling General Administrative28,171,000USD29,094,000USD26,555,000USD25,742,000USD854,000USD7,567,000USD6,748,000USD6,905,000USD
    Total Operating Expenses45,030,000USD44,616,000USD38,464,000USD36,197,000USD36,157,000USD75,949,000USD65,459,000USD50,656,000USD
    Operating Income-6,326,000USD4,449,000USD14,089,000USD13,514,000USD1,374,000USD11,367,000USD-24,176,000USD-22,136,000USD
    Total Other Income Expense Net-2,512,000USD-3,294,000USD-13,842,000USD-7,402,000USD-760,000USD913,000USD1,042,000USD618,000USD
    Income Before Tax-8,838,000USD1,155,000USD247,000USD6,112,000USD614,000USD12,280,000USD-23,134,000USD-21,518,000USD
    Income Tax Expense70,000USD615,000USD——-1,000USD0USD-842,000USD-608,000USD
    Net Income-8,908,000USD540,000USD247,000USD6,112,000USD614,000USD12,280,000USD-23,134,000USD-21,518,000USD
    Interest Expense—4,748,000USD6,834,000USD7,770,000USD1,418,000USD913,000USD842,000USD608,000USD
    Net Interest Income—-4,748,000USD-6,834,000USD-7,770,000USD-1,418,000USD———
    Tax Provision—615,000USD—0USD————
    Net Income From Continuing Ops—540,000USD247,000USD6,112,000USD614,000USD12,281,000USD-23,134,000USD-21,518,000USD
    Ebit—5,903,000USD7,081,000USD13,882,000USD2,032,000USD11,367,000USD-24,176,000USD-22,136,000USD
    Ebitda—6,221,000USD7,397,000USD14,196,000USD11,436,000USD11,564,000USD-24,009,000USD-22,018,000USD
    Depreciation And Amortization—318,000USD316,000USD314,000USD9,404,000USD197,000USD167,000USD118,000USD
    Reconciled Depreciation—318,000USD316,000USD314,000USD14,844,000USD197,000USD167,000USD118,000USD
    Selling And Marketing Expenses————25,436,000USD———
    Non Operating Income Net Other—————-1,885,000USD1,042,000USD618,000USD
    Minority Interest—————0USD0USD0USD
    Discontinued Operations—————0USD0USD0USD
    Net Income Applicable To Common Shares—————12,281,000USD-23,134,000USD-21,518,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20162016-12-31 · USDFY 20152015-12-31 · USDFY 20142014-12-31 · USD
    Total Revenue236,196,000USD1,535,000USD0USD700,233USD
    Cost Of Revenue39,462,000USD115,785,000USD96,000USD23,263,000USD
    Gross Profit196,734,000USD-114,250,000USD-96,000USD-23,263,000USD
    Research Development62,359,000USD115,785,000USD43,016,000USD25,398,000USD
    Selling General Administrative107,480,000USD22,210,000USD18,497,000USD12,542,000USD
    Unclassified Operating Expenses3,396,000USD———
    Total Operating Expenses173,235,000USD137,995,000USD61,513,000USD37,940,000USD
    Operating Income23,499,000USD-136,460,000USD-61,513,000USD-37,940,000USD
    Interest Expense24,179,000USD901,000USD510,000USD206,000USD
    Net Interest Income-24,179,000USD901,000USD——
    Income Before Tax-3,721,000USD-135,747,000USD-60,716,000USD-37,034,000USD
    Income Tax Expense1,624,000USD-901,000USD-510,000USD-206,000USD
    Tax Provision1,624,000USD———
    Net Income-5,345,000USD-135,747,000USD-60,716,000USD-37,034,000USD
    Net Income From Continuing Ops-5,345,000USD-135,747,000USD-60,716,000USD-37,734,000USD
    Ebit20,458,000USD-136,460,000USD-61,513,000USD-37,940,000USD
    Ebitda21,727,000USD-136,164,000USD-61,417,000USD-37,891,000USD
    Depreciation And Amortization1,269,000USD296,000USD96,000USD49,000USD
    Reconciled Depreciation1,269,000USD———
    Total Other Income Expense Net-27,220,000USD713,000USD497,000USD906,000USD
    Interest Income—901,000USD——
    Non Operating Income Net Other—713,000USD287,000USD—
    Net Income Applicable To Common Shares—-135,747,000USD-60,716,000USD-123,933,594USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets349,658,000USD362,520,000USD376,565,000USD364,152,000USD345,595,000USD310,185,000USD220,670,000USD207,142,000USD
    Cash And Equivalents155,548,000USD———————
    Total Current Assets229,553,000USD243,481,000USD252,955,000USD258,336,000USD234,657,000USD203,782,000USD113,831,000USD100,120,000USD
    Other Current Assets7,481,000USD5,305,000USD5,470,000USD7,026,000USD7,832,000USD9,138,000USD11,350,001USD13,438,000USD
    Other Non Current Assets53,747,000USD———————
    Total Liabilities324,640,000USD———————
    Total Current Liabilities160,865,000USD173,884,000USD162,938,000USD133,379,000USD118,717,000USD91,227,000USD80,914,000USD65,709,000USD
    Other Current Liabilities109,797,000USD———————
    Other Non Current Liabilities562,000USD———————
    Total Stockholder Equity25,018,000USD27,375,000USD32,610,000USD41,592,000USD29,224,000USD24,581,000USD-49,185,000USD-50,402,000USD
    Total Equity Including Noncontrolling Interest25,018,000USD———————
    Short Long Term Debt24,809,000USD12,495,000USD——————
    Long Term Debt24,754,000USD36,395,000USD48,250,000USD47,641,000USD47,062,000USD46,511,000USD38,693,000USD38,355,000USD
    Deferred Revenue6,169,000USD———————
    Net Receivables53,506,000USD62,536,000USD47,031,000USD66,223,000USD72,809,000USD61,538,000USD34,368,000USD32,170,000USD
    Inventory13,018,000USD12,996,000USD15,610,000USD18,643,000USD16,708,000USD19,732,000USD16,242,999USD20,493,000USD
    Property Plant Equipment Net7,314,000USD3,421,000USD4,885,000USD6,310,000USD7,701,000USD9,018,000USD10,418,000USD11,833,000USD
    Goodwill59,044,000USD———————
    Accounts Payable9,422,000USD8,386,000USD21,185,000USD10,087,000USD11,554,000USD12,658,000USD15,180,000USD13,494,000USD
    Common Stock2,000USD2,000USD2,000USD2,000USD2,000USD2,000USD2,000USD2,000USD
    Retained Earnings-1,701,667,000USD-1,692,759,000USD-1,683,705,000USD-1,671,461,000USD-1,672,001,000USD-1,672,248,000USD-1,678,360,000USD-1,655,556,000USD
    Accumulated Other Comprehensive Income6,000USD6,000USD6,000USD6,000USD6,000USD6,000USD6,000USD6,000USD
    Total Liab—335,145,000USD343,955,000USD322,560,000USD316,371,000USD285,604,000USD269,855,000USD257,544,000USD
    Other Current Liab—148,507,000USD135,524,000USD114,475,000USD96,002,000USD71,814,000USD56,021,000USD44,691,000USD
    Capital Stock—2,000USD2,000USD2,000USD2,000USD2,000USD2,000USD2,000USD
    Good Will—59,044,000USD59,044,000USD59,044,000USD59,044,000USD59,044,000USD59,044,000USD59,044,000USD
    Cash—162,644,000USD184,844,000USD166,444,000USD137,308,000USD113,374,000USD51,870,000USD34,019,000USD
    Cash And Short Term Investments—162,644,000USD184,844,000USD166,444,000USD137,308,000USD113,374,000USD51,870,000USD34,019,000USD
    Current Deferred Revenue—4,496,000USD2,681,000USD3,881,000USD5,532,000USD1,241,000USD15,727,000USD—
    Net Debt—-150,149,000USD-133,046,000USD-113,867,000USD-83,946,000USD-59,226,000USD136,859,000USD16,797,000USD
    Short Term Debt—12,495,000USD3,548,000USD4,936,000USD5,629,000USD5,514,000USD9,713,000USD7,524,000USD
    Short Long Term Debt Total—12,495,000USD51,798,000USD52,577,000USD53,362,000USD54,148,000USD188,729,000USD50,816,000USD
    Property Plant Equipment Gross—3,421,000USD4,885,000USD6,310,000USD7,701,000USD9,018,000USD10,418,000USD11,833,000USD
    Common Stock Shares Outstanding—267,046,755shares265,369,385shares274,372,722shares271,104,020shares241,602,853shares218,699,008shares210,348,459shares
    Non Current Assets Total—119,039,000USD123,610,000USD105,816,000USD110,938,000USD106,403,000USD106,839,000USD107,022,000USD
    Non Current Liabilities Total—161,261,000USD181,017,000USD189,181,000USD197,654,000USD194,377,000USD188,941,000USD191,835,000USD
    Non Current Liabilities Other—105,937,000USD107,181,000USD108,572,000USD105,166,000USD104,103,000USD103,512,000USD104,839,000USD
    Non Currrent Assets Other—56,574,000USD59,681,000USD40,462,000USD42,503,000USD36,656,000USD37,377,000USD25,460,000USD
    Net Working Capital—69,597,000USD90,017,000USD124,957,000USD115,940,000USD112,555,000USD32,917,000USD34,411,000USD
    Unclassified Current Liabilities—-12,495,000USD————-15,727,000USD—
    Unclassified Non Current Liabilities—18,929,000USD25,586,000USD32,968,000USD45,426,000USD43,763,000USD46,736,000USD48,641,000USD
    Unclassified Equity—1,720,124,000USD1,716,305,000USD1,713,043,000USD1,701,215,000USD1,696,819,000USD1,629,165,000USD1,605,144,000USD
    Unclassified Non Current Assets————1,690,000USD1,685,000USD—1,674,000USD
    Intangible Assets———————9,011,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets376,565,000USD220,670,000USD241,703,000USD356,054,000USD529,347,000USD644,139,000USD771,201,000USD996,540,000USD
    Other Current Assets-62,641,000USD11,350,001USD20,243,000USD32,864,000USD33,140,000USD12,760,000USD6,363,000USD31,448,000USD
    Total Liab343,955,000USD269,855,000USD272,287,000USD350,824,000USD455,339,000USD396,521,000USD376,444,000USD360,612,000USD
    Total Stockholder Equity32,610,000USD-49,185,000USD-30,584,000USD5,230,000USD74,008,000USD247,618,000USD394,757,000USD635,928,000USD
    Other Current Liab101,669,000USD56,021,000USD61,196,000USD71,033,000USD104,212,000USD87,289,000USD93,530,000USD150,917,000USD
    Common Stock2,000USD2,000USD2,000USD2,000USD1,000USD1,000USD1,000USD1,000USD
    Capital Stock2,000USD2,000USD2,000USD2,000USD1,000USD1,000USD1,000USD1,000USD
    Retained Earnings-1,683,705,000USD-1,678,360,000USD-1,608,950,000USD-1,557,025,000USD-1,462,799,000USD-1,177,511,000USD-794,054,000USD-514,395,000USD
    Good Will59,044,000USD59,044,000USD59,044,000USD59,044,000USD59,044,000USD55,053,000USD55,053,000USD55,053,000USD
    Cash184,844,000USD51,870,000USD42,925,000USD90,466,000USD149,800,000USD229,093,000USD147,712,000USD104,644,000USD
    Cash And Short Term Investments184,844,000USD51,870,000USD42,925,000USD90,466,000USD149,800,000USD269,085,000USD147,957,000USD321,640,000USD
    Total Current Assets184,844,000USD113,831,000USD118,149,000USD185,182,000USD271,149,000USD371,437,000USD309,533,000USD468,275,000USD
    Total Current Liabilities162,938,000USD80,914,000USD99,870,000USD129,536,000USD261,051,000USD187,146,000USD208,118,000USD265,693,000USD
    Net Debt31,454,000USD136,859,000USD61,257,000USD9,317,000USD39,327,000USD-102,808,000USD-39,390,000USD-89,644,000USD
    Short Term Debt40,084,000USD9,713,000USD24,039,000USD36,744,000USD102,345,000USD5,286,000USD4,989,000USD15,000,000USD
    Short Long Term Debt Total216,298,000USD188,729,000USD104,182,000USD99,783,000USD189,127,000USD126,285,000USD108,322,000USD15,000,000USD
    Long Term Debt48,250,000USD38,693,000USD17,183,000USD34,078,000USD1,820,000USD98,798,000USD77,455,000USD—
    Net Receivables47,031,000USD34,368,000USD39,290,000USD40,284,000USD51,581,000USD28,575,000USD38,864,000USD16,666,000USD
    Inventory15,610,000USD16,242,999USD15,691,000USD21,568,000USD36,628,000USD61,017,000USD116,349,000USD114,245,000USD
    Accounts Payable21,185,000USD15,180,000USD14,635,000USD18,021,000USD33,588,000USD41,308,000USD39,217,000USD42,796,000USD
    Property Plant Equipment Net4,885,000USD10,418,000USD16,045,000USD34,372,000USD40,606,000USD35,498,000USD39,418,000USD8,023,000USD
    Property Plant Equipment Gross4,885,000USD10,418,000USD16,045,000USD43,691,000USD48,271,000USD35,498,000USD10,380,000USD8,023,000USD
    Accumulated Other Comprehensive Income6,000USD6,000USD6,000USD6,000USD6,000USD13,000USD0USD-261,000USD
    Common Stock Shares Outstanding257,157,782shares210,946,658shares187,465,448shares182,782,680shares165,949,695shares138,463,152shares118,395,919shares116,887,518shares
    Non Current Assets Total191,721,000USD106,839,000USD123,554,000USD170,872,000USD258,198,000USD272,702,000USD461,668,000USD528,265,000USD
    Non Current Liabilities Total181,017,000USD188,941,000USD172,417,000USD221,288,000USD194,288,000USD209,375,000USD168,326,000USD94,919,000USD
    Non Current Liabilities Other107,181,000USD103,512,000USD62,898,000USD98,476,000USD190,781,000USD110,577,000USD90,871,000USD85,282,000USD
    Non Currrent Assets Other132,677,000USD37,377,000USD12,423,000USD5,372,000USD50,421,000USD35,942,000USD73,893,000USD21,804,000USD
    Net Working Capital90,017,000USD32,917,000USD18,279,000USD60,193,000USD15,517,000USD184,291,000USD101,415,000USD202,582,000USD
    Unclassified Current Assets-62,641,000USD——————-15,724,000USD
    Unclassified Non Current Assets-4,885,000USD——-94,483,000USD-640,266,000USD-62,818,000USD-73,893,000USD-21,804,000USD
    Unclassified Non Current Liabilities25,586,000USD46,736,000USD92,336,000USD-69,515,000USD-157,211,000USD-88,376,000USD-64,993,000USD-94,919,000USD
    Unclassified Equity1,716,305,000USD1,629,165,000USD1,578,356,000USD1,562,245,000USD1,536,799,000USD1,425,114,000USD1,188,809,000USD1,150,582,000USD
    Current Deferred Revenue—15,727,000USD22,940,000USD3,738,000USD20,906,000USD53,263,000USD70,382,000USD56,980,000USD
    Unclassified Current Liabilities—-15,727,000USD-40,440,000USD-32,000,000USD-97,543,000USD——-15,000,000USD
    Intangible Assets——36,042,000USD72,084,000USD108,127,000USD144,170,000USD291,212,000USD328,153,000USD
    Short Long Term Debt——17,500,000USD32,000,000USD97,543,000USD——15,000,000USD
    Other Liab———158,249,000USD158,898,000USD88,376,000USD64,993,000USD94,919,000USD
    Other Assets———94,483,000USD640,266,000USD64,857,000USD75,985,000USD137,036,000USD
    Net Tangible Assets———-117,795,000USD-86,724,000USD48,395,000USD48,492,000USD252,722,000USD
    Short Term Investments————0USD39,992,000USD245,000USD216,996,000USD
    Deferred Long Term Liab———————9,637,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income-9,054,000USD-12,244,000USD540,000USD247,000USD6,112,000USD-22,804,000USD-20,039,000USD-8,582,000USD
    Depreciation328,000USD321,000USD318,000USD316,000USD314,000USD13,543,000USD9,374,000USD9,410,000USD
    Stock Based Compensation3,668,000USD3,199,000USD3,221,000USD2,676,000USD2,187,000USD1,697,000USD1,646,000USD2,072,000USD
    Other Non Cash Items8,393,000USD17,982,000USD4,799,000USD14,006,000USD7,526,000USD8,026,000USD9,979,000USD677,000USD
    Change To Account Receivables-15,704,000USD19,098,000USD6,160,000USD-11,528,000USD-27,872,000USD-3,074,000USD-2,405,000USD-3,145,000USD
    Change To Inventory-2,540,000USD-17,418,000USD6,899,000USD-7,653,000USD-4,953,000USD-8,496,000USD-545,000USD-14,926,000USD
    Change In Working Capital-24,542,000USD21,871,000USD19,227,000USD5,100,000USD-29,726,000USD-3,231,000USD-7,655,000USD-13,643,000USD
    Total Cash From Operating Activities-21,207,000USD31,129,000USD28,105,000USD22,345,000USD-13,587,000USD-4,466,000USD-6,695,000USD-10,066,000USD
    Capital Expenditures-62,000USD-162,000USD-77,000USD-126,000USD-18,000USD-2,000USD-2,000USD-29,000USD
    Free Cash Flow-21,207,000USD30,967,000USD28,028,000USD22,219,000USD-13,605,000USD-4,468,000USD-6,697,000USD-10,095,000USD
    Total Cashflows From Investing Activities-62,000USD-7,877,000USD-77,000USD-126,000USD154,000USD-2,000USD-2,000USD-29,000USD
    Net Borrowings0USD0USD0USD0USD9,538,000USD1,000USD0USD—
    Total Cash From Financing Activities-926,000USD-4,848,000USD1,113,000USD1,720,000USD74,942,000USD22,325,000USD1,223,000USD7,640,000USD
    Sale Purchase Of Stock0USD-126,000USD63,000USD—-63,000USD—750,000USD—
    Issuance Of Capital Stock131,000USD0USD152,000USD1,542,000USD64,985,000USD22,094,000USD1,745,000USD0USD
    Change In Cash-22,195,000USD18,404,000USD29,141,000USD23,934,000USD61,509,000USD17,851,000USD-5,474,000USD-2,462,000USD
    Begin Period Cash Flow186,543,000USD168,139,000USD138,998,000USD113,374,000USD53,550,000USD34,019,000USD41,167,000USD41,961,000USD
    End Period Cash Flow164,348,000USD186,543,000USD168,139,000USD137,308,000USD115,059,000USD51,870,000USD35,693,000USD39,499,000USD
    Other Cashflows From Investing Activities-62,000USD-7,887,000USD-49,000USD—172,000USD—-31,000USD-29,000USD
    Other Cashflows From Financing Activities-926,000USD-4,848,000USD961,000USD115,000USD482,000USD1,272,000USD-522,000USD-736,000USD
    Investments——-77,000USD-126,000USD154,000USD-2,000USD-2,000USD-29,000USD
    Unclassified Financing Cash Flow————64,985,000USD-1,042,000USD—8,376,000USD
    Unclassified Operating Cash Flow—————-1,697,000USD——
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Net Income-5,345,000USD-69,410,000USD-51,925,000USD-92,562,000USD-282,024,000USD-383,457,000USD-279,659,000USD-143,588,000USD
    Depreciation1,269,000USD37,504,000USD41,846,000USD37,697,000USD36,128,000USD33,590,000USD38,646,000USD2,421,000USD
    Stock Based Compensation11,283,000USD7,775,000USD9,317,000USD17,849,000USD22,735,000USD24,460,000USD11,925,000USD19,040,000USD
    Other Non Cash Items44,313,000USD23,148,000USD-1,895,000USD-34,703,000USD98,542,000USD24,611,000USD77,347,000USD16,953,000USD
    Change To Account Receivables-14,142,000USD4,046,000USD994,000USD11,695,000USD-24,027,000USD12,011,000USD-22,198,000USD33,384,000USD
    Change To Inventory-23,125,000USD-28,401,000USD-2,542,000USD19,793,000USD-24,947,000USD6,163,000USD-29,142,000USD26,000USD
    Change In Working Capital16,472,000USD-39,676,000USD-20,727,000USD-1,435,000USD-105,611,000USD-13,670,000USD-99,069,000USD36,018,000USD
    Total Cash From Operating Activities67,992,000USD-40,659,000USD-23,384,000USD-73,154,000USD-252,965,000USD-110,388,000USD-257,441,000USD-97,494,000USD
    Capital Expenditures-291,000USD-33,000USD0USD-114,000USD-59,000USD-317,000USD-6,655,000USD-1,606,000USD
    Free Cash Flow67,992,000USD-40,692,000USD-23,384,000USD-73,268,000USD-253,024,000USD-110,705,000USD-264,096,000USD-99,100,000USD
    Total Cashflows From Investing Activities-7,926,000USD-33,000USD—-114,000USD39,941,000USD-40,004,000USD211,176,000USD36,594,000USD
    Net Borrowings9,538,000USD7,901,000USD-32,000,000USD-33,000,000USD-33,000,000USD19,975,000USD62,668,000USD-19,000USD
    Total Cash From Financing Activities72,927,000USD49,663,000USD-25,206,000USD14,598,000USD133,731,000USD231,720,000USD88,970,000USD96,562,000USD
    Issuance Of Capital Stock66,679,000USD42,649,000USD-1,000USD7,121,000USD88,202,000USD209,419,000USD25,785,000USD95,452,000USD
    Change In Cash132,993,000USD8,971,000USD-48,590,000USD-58,670,000USD-79,293,000USD81,328,000USD42,705,000USD35,662,000USD
    Begin Period Cash Flow53,550,000USD44,579,000USD93,169,000USD151,839,000USD229,093,000USD149,804,000USD107,099,000USD71,437,000USD
    End Period Cash Flow186,543,000USD53,550,000USD44,579,000USD93,169,000USD149,800,000USD231,132,000USD149,804,000USD107,099,000USD
    Other Cashflows From Investing Activities-7,926,000USD———40,000,000USD-39,687,000USD217,831,000USD32,053,000USD
    Other Cashflows From Financing Activities-63,000USD385,000USD1,000USD40,067,000USD133,731,000USD1,226,000USD560,000USD647,000USD
    Unclassified Financing Cash Flow-3,227,000USD42,649,000USD6,793,000USD—-55,948,000USD—26,168,000USD—
    Investments—-33,000USD0USD-114,000USD40,000,000USD-39,687,000USD217,831,000USD32,053,000USD
    Sale Purchase Of Stock—-1,272,000USD0USD7,598,000USD88,948,000USD211,745,000USD-426,000USD96,581,000USD
    Change To Liabilities———-34,646,000USD-48,896,000USD10,034,000USD-25,979,000USD69,199,000USD
    Cash And Cash Equivalents Changes———-58,670,000USD-79,293,000USD81,328,000USD42,705,000USD35,662,000USD
    Unclassified Operating Cash Flow————-22,735,000USD204,078,000USD-6,631,000USD-28,338,000USD
    Unclassified Investing Cash Flow————-40,000,000USD39,687,000USD-217,831,000USD-25,906,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q1 2026Quarterly · 2026-03-31ProductAmended Supply Agreement0USD0001517022-26-000039
    Q1 2026Quarterly · 2026-03-31ProductAuryxia36,190,000USD0001517022-26-000039
    Q1 2026Quarterly · 2026-03-31ProductLicense Collaboration And Other Revenue1,552,000USD0001517022-26-000039
    Q1 2026Quarterly · 2026-03-31ProductLicense Collaboration And Other Revenue Royalties300,000USD0001517022-26-000039
    Q1 2026Quarterly · 2026-03-31ProductSupply Agreement0USD0001517022-26-000039
    Q1 2026Quarterly · 2026-03-31ProductVafseo15,802,000USD0001517022-26-000039
    Q4 2025Quarterly · 2025-12-31ProductAuryxia48,135,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31ProductLicense Collaboration And Other Revenue3,331,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31ProductLicense Collaboration And Other Revenue Royalties500,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31ProductSupply Agreement300,000USDLegacy provider
    Q4 2025Quarterly · 2025-12-31ProductVafseo6,155,000USDLegacy provider
    FY 2025Yearly · 2025-12-31ProductAmended Supply Agreement0USD0001517022-26-000020
    FY 2025Yearly · 2025-12-31ProductAuryxia181,542,000USD0001517022-26-000020
    FY 2025Yearly · 2025-12-31ProductLicense Collaboration And Other Revenue8,864,000USD0001517022-26-000020
    FY 2025Yearly · 2025-12-31ProductLicense Collaboration And Other Revenue Royalties1,900,000USD0001517022-26-000020
    FY 2025Yearly · 2025-12-31ProductSupply Agreement300,000USD0001517022-26-000020
    FY 2025Yearly · 2025-12-31ProductVafseo45,790,000USD0001517022-26-000020
    Q3 2025Quarterly · 2025-09-30ProductAuryxia42,467,000USD0001517022-25-000046
    Q3 2025Quarterly · 2025-09-30ProductLicense Collaboration And Other Revenue1,977,000USD0001517022-25-000046
    Q3 2025Quarterly · 2025-09-30ProductLicense Collaboration And Other Revenue Royalties500,000USD0001517022-25-000046
    Q3 2025Quarterly · 2025-09-30ProductSupply Agreement0USD0001517022-25-000046
    Q3 2025Quarterly · 2025-09-30ProductVafseo14,322,000USD0001517022-25-000046
    Q2 2025Quarterly · 2025-06-30ProductAuryxia47,183,000USD0001628280-25-038600
    Q2 2025Quarterly · 2025-06-30ProductLicense Collaboration And Other Revenue2,011,000USD0001628280-25-038600
    Q2 2025Quarterly · 2025-06-30ProductLicense Collaboration And Other Revenue Royalties500,000USD0001628280-25-038600
    Q2 2025Quarterly · 2025-06-30ProductSupply Agreement0USD0001628280-25-038600
    Q2 2025Quarterly · 2025-06-30ProductVafseo13,279,000USD0001628280-25-038600
    Q1 2025Quarterly · 2025-03-31ProductAmended Supply Agreement0USD0001517022-26-000039
    Q1 2025Quarterly · 2025-03-31ProductAuryxia43,757,000USD0001517022-26-000039
    Q1 2025Quarterly · 2025-03-31ProductLicense Collaboration And Other Revenue1,545,000USD0001517022-26-000039
    Q1 2025Quarterly · 2025-03-31ProductLicense Collaboration And Other Revenue Royalties400,000USD0001517022-26-000039
    Q1 2025Quarterly · 2025-03-31ProductSupply Agreement0USD0001517022-26-000039
    Q1 2025Quarterly · 2025-03-31ProductVafseo12,034,000USD0001517022-26-000039
    FY 2024Yearly · 2024-12-31ProductLicense1,000,000USD0001628280-25-012470
    FY 2024Yearly · 2024-12-31ProductLicense Collaboration And Other Revenue8,000,000USD0001628280-25-012470
    FY 2024Yearly · 2024-12-31ProductLicense Collaboration And Other Revenue Royalties0USD0001628280-25-012470
    FY 2024Yearly · 2024-12-31ProductProduct152,200,000USD0001628280-25-012470
    FY 2024Yearly · 2024-12-31ProductSupply Agreement0USD0001628280-25-012470
    FY 2023Yearly · 2023-12-31ProductLicense Collaboration And Other Revenue24,322,000USD0001628280-25-012470
    FY 2023Yearly · 2023-12-31ProductLicense Collaboration And Other Revenue Royalties0USD0001628280-25-012470
    FY 2023Yearly · 2023-12-31ProductProduct170,300,000USD0001628280-25-012470
    FY 2023Yearly · 2023-12-31ProductSupply Agreement0USD0001628280-25-012470
    Q2 2023Quarterly · 2023-06-30ProductLicense Collaboration And Other Revenue14,132,000USD0001628280-24-035879
    Q2 2023Quarterly · 2023-06-30ProductLicense Collaboration And Other Revenue Royalties500,000USD0001628280-24-035879
    Q2 2023Quarterly · 2023-06-30ProductProduct42,200,000USD0001628280-24-035879
    Q1 2023Quarterly · 2023-03-31ProductLicense Collaboration And Other Revenue5,299,000USD0001628280-24-021945
    Q1 2023Quarterly · 2023-03-31ProductLicense Collaboration And Other Revenue Royalties400,000USD0001628280-24-021945
    Q1 2023Quarterly · 2023-03-31ProductProduct34,700,000USD0001628280-24-021945
    Q4 2022Quarterly · 2022-12-31ProductLicense Collaboration And Other Revenue4,403,000USDLegacy provider
    Q4 2022Quarterly · 2022-12-31ProductProduct50,200,000USDLegacy provider
    FY 2022Yearly · 2022-12-31ProductLicense Collaboration And Other Revenue115,535,000USD0001628280-24-011270
    FY 2022Yearly · 2022-12-31ProductProduct176,900,000USD0001628280-24-011270
    FY 2021Yearly · 2021-12-31ProductLicense Collaboration And Other Revenue71,362,000USD0001628280-23-007539
    FY 2021Yearly · 2021-12-31ProductProduct142,200,000USD0001628280-23-007539
    FY 2019Yearly · 2019-12-31ProductLicense Collaboration And Other Revenue223,882,000USD0001628280-22-004522
    FY 2019Yearly · 2019-12-31ProductProduct111,100,000USD0001628280-22-004522
    FY 2018Yearly · 2018-12-31ProductLicense Collaboration And Other Revenue200,918,000USD0001628280-21-003283
    FY 2018Yearly · 2018-12-31ProductProduct6,824,000USD0001628280-21-003283

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.